The company was conceived not only as an operator that provides medicines and medical equipment, etc., but above all as an operator that provides health care services through the provision of qualitative and safe medicines for Albanian citizens. Medicines according Almegipharma are a solution and not just a choise for our health problems. Furthermore, Almegipharma has performed a daily communication with doctors and consumers. Updating the knowledge of doctors and pharmacists through participation in medical conferences and congresses, organization of seminars and round tables in order to share health problems and providing educational forms for patients has made a real difference in the Albanian pharmaceutical market, not only for the volume of business but also for the quality of medicines and its partners in this market. Almegipharma since the beginning gained the confidence of the American company "Eli Lilly". This cooperation still continues today, providing qualitative medication for the treatment of diabetes, infectious and oncologic diseases, mental health, growth deficiencies, etc. After that the cooperation continued with well known pharmaceutical companies as UCB with te most qualitative medicines for the treatment of allergy, epilepsy, Parkinson's, cognitive diseases etc. and further more to continue with GRIFOLS, AlkAbelo, Mentholatum, Aegis, Bioclin, Allergopharma and finally with ASAC Pharma offering to Albanian patients not only personalized vaccines for allergy but for the first time the bacterial vaccines too. Almegipharma is focused on innovative solutions to health problems of Albanian citizens and as such is interested in contacting and possibly collaboraing with other pharmaceutical companies from Europe and worldwide offering new medications in the Albanian pharmaceutical market, based on partnership and mutual interest. Our vision is to contribute for a country with healthy citizens, able to build their future in wellness. Our mission is to contribute to the improvement of Albanian ...
| Website | http://www.almegipharma.com |
| Revenue | $3 million |
| Employees | View employees |
| Phone | +355 4 241 3536 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Teva Pharmaceuticals, Mylan Belgium, Sandoz, SUN PHARMA, Aurobindo Pharma LTD, Dr. Reddy's Laboratories, Zydus Cadila Healthcare Limited, Hikma Pharmaceuticals, Amgen, Merck & Co., Inc. +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Almegipharma employee's phone or email?
The Almegipharma annual revenue was $3 million in 2026.
The NAICS codes for Almegipharma are [32541, 3254, 325, 32].
The SIC codes for Almegipharma are [283, 28].